Amoxapine/Prednisolone

阿莫沙平/泼尼松龙

Report date: 2022/01/24 09:15:45

Base Information

Drug NameAmoxapine/Prednisolone
Drug Alias Name泼尼松龙/阿莫沙平Amoxapine+PrednisolonePrednisolone+Amoxapine泼尼松龙+阿莫沙平阿莫沙平+泼尼松龙 +[7
ClassificationSmall molecules > Steroids
Mechanisms of ActionMonoamine reuptake inhibitorGlucocorticoid receptor agonists
TargetsGlucocorticoid receptorMonoamine transporters
Therapy Area/IndicationsAutoimmune DiseasesPeriodontitisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes PrednisoloneAmoxapine
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCombinatorx
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCombinatorx
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesPeriodontitisArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A